Portfolio company
evitria AG
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company produces custom recombinant antibodies and proteins for global biopharmaceutical firms, biotechnology startups and academic laboratories.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
53Biologics
This company provides contract development and manufacturing services for recombinant proteins and plasmid DNA to biotechnology and pharmaceutical firms.
Adaptyv Bio
This company operates an automated laboratory platform for protein design validation, serving pharmaceutical firms, biotech startups, and artificial intelligence research laboratories.
BioCeros
This company provides cell line development services for monoclonal antibody production to biotechnology firms, pharmaceutical companies and academic institutions.
Future Fields
This company produces recombinant proteins using genetically engineered fruit flies for customers in the biotechnology, pharmaceutical, and cellular agriculture sectors.
BioGenes
BioGenes develops custom antibodies and immunoassay kits for pharmaceutical and biotechnology companies to support drug development and quality control.
Kyron.bio
This company develops glycan-engineering technology to improve therapeutic proteins and antibodies for pharmaceutical firms and research institutions.
redbiotec
This company develops proteins and genetic materials for the biopharma and food industries, including engineered bacteria for cancer and genetic disorder therapies.
LabGenius
This biopharmaceutical company develops therapeutic antibodies using an automated protein engineering platform for pharmaceutical and biotechnology partners.